CN114080181A - 用于生理系统干扰的神经调节技术 - Google Patents
用于生理系统干扰的神经调节技术 Download PDFInfo
- Publication number
- CN114080181A CN114080181A CN202080048471.3A CN202080048471A CN114080181A CN 114080181 A CN114080181 A CN 114080181A CN 202080048471 A CN202080048471 A CN 202080048471A CN 114080181 A CN114080181 A CN 114080181A
- Authority
- CN
- China
- Prior art keywords
- energy
- concentration
- subject
- target region
- glucose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0048—Detecting, measuring or recording by applying mechanical forces or stimuli
- A61B5/0051—Detecting, measuring or recording by applying mechanical forces or stimuli by applying vibrations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14503—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14546—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
- A61B5/414—Evaluating particular organs or parts of the immune or lymphatic systems
- A61B5/416—Evaluating particular organs or parts of the immune or lymphatic systems the spleen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/42—Detecting, measuring or recording for evaluating the gastrointestinal, the endocrine or the exocrine systems
- A61B5/4222—Evaluating particular parts, e.g. particular organs
- A61B5/4244—Evaluating particular parts, e.g. particular organs liver
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/42—Detecting, measuring or recording for evaluating the gastrointestinal, the endocrine or the exocrine systems
- A61B5/4222—Evaluating particular parts, e.g. particular organs
- A61B5/425—Evaluating particular parts, e.g. particular organs pancreas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
- A61B5/6813—Specially adapted to be attached to a specific body part
- A61B5/6823—Trunk, e.g., chest, back, abdomen, hip
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
- A61B5/6847—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
- A61B5/686—Permanently implanted devices, e.g. pacemakers, other stimulators, biochips
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/0526—Head electrodes
- A61N1/0529—Electrodes for brain stimulation
- A61N1/0536—Preventing neurodegenerative response or inflammatory reaction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36014—External stimulators, e.g. with patch electrodes
- A61N1/36017—External stimulators, e.g. with patch electrodes with leads or electrodes penetrating the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N7/00—Ultrasound therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N7/00—Ultrasound therapy
- A61N2007/0004—Applications of ultrasound therapy
- A61N2007/0021—Neural system treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N7/00—Ultrasound therapy
- A61N2007/0004—Applications of ultrasound therapy
- A61N2007/0021—Neural system treatment
- A61N2007/0026—Stimulation of nerve tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N7/00—Ultrasound therapy
- A61N2007/0073—Ultrasound therapy using multiple frequencies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N7/00—Ultrasound therapy
- A61N2007/0078—Ultrasound therapy with multiple treatment transducers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Surgery (AREA)
- Molecular Biology (AREA)
- Medical Informatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Neurology (AREA)
- Optics & Photonics (AREA)
- Endocrinology (AREA)
- Physiology (AREA)
- Cardiology (AREA)
- Psychology (AREA)
- Neurosurgery (AREA)
- Emergency Medicine (AREA)
- Immunology (AREA)
- Vascular Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Surgical Instruments (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16/399,692 US11426610B2 (en) | 2019-04-30 | 2019-04-30 | Neuromodulation techniques for perturbation of physiological systems |
PCT/US2020/038665 WO2020223741A2 (fr) | 2019-04-30 | 2020-06-19 | Techniques de neuromodulation pour perturbation de systèmes physiologiques |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114080181A true CN114080181A (zh) | 2022-02-22 |
Family
ID=71083670
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202080048471.3A Pending CN114080181A (zh) | 2019-04-30 | 2020-06-19 | 用于生理系统干扰的神经调节技术 |
Country Status (5)
Country | Link |
---|---|
US (2) | US11426610B2 (fr) |
EP (1) | EP3962598A4 (fr) |
JP (1) | JP2022536025A (fr) |
CN (1) | CN114080181A (fr) |
WO (2) | WO2020222217A1 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022180184A1 (fr) * | 2021-02-24 | 2022-09-01 | Indigo Diabetes Nv | Système de surveillance de santé en continu |
CA3227424A1 (fr) * | 2021-07-27 | 2023-02-02 | The Regents Of The University Of California | Detection de signaux neuronaux de reponses immunitaires |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6615081B1 (en) | 1998-10-26 | 2003-09-02 | Birinder R. Boveja | Apparatus and method for adjunct (add-on) treatment of diabetes by neuromodulation with an external stimulator |
US7323296B2 (en) | 2004-10-01 | 2008-01-29 | Yuanhong Ma | Method and index for diagnosing insulin resistance |
CN102149428B (zh) | 2008-07-14 | 2015-07-08 | 代理并代表亚利桑那州立大学的亚利桑那董事会 | 使用超声用于调节细胞活性的方法和装置 |
US20130184728A1 (en) | 2011-11-29 | 2013-07-18 | David J. Mishelevich | Ultrasound Neuromodulation for Diagnosis and Other-Modality Preplanning |
US8235897B2 (en) | 2010-04-27 | 2012-08-07 | A.D. Integrity Applications Ltd. | Device for non-invasively measuring glucose |
WO2015069446A1 (fr) | 2013-11-06 | 2015-05-14 | Towe Bruce C | Modulation induite par ultrasons de niveaux de glycémie |
WO2016072875A1 (fr) * | 2014-11-03 | 2016-05-12 | Glaxosmithkline Intellectual Property Development Limited | Dispositif de neuromodulation |
US20160236012A1 (en) | 2015-02-18 | 2016-08-18 | The George Washington University a Congressionally Chartered Not-for-Profit Corporation | Ultrasound stimulation of pancreatic beta cells |
US20170100605A1 (en) | 2015-05-15 | 2017-04-13 | Ohio State Innovation Foundation | Systems and methods of improving an immune disorder |
EP3439736A1 (fr) | 2016-04-04 | 2019-02-13 | General Electric Company | Techniques de neuromodulation |
WO2018022902A1 (fr) * | 2016-07-27 | 2018-02-01 | The Trustees Of Columbia University In The City Of New York | Procédés et systèmes de modulation de nerfs périphériques utilisant des ultrasons focalisés |
AU2017348440C1 (en) * | 2016-10-31 | 2023-07-20 | General Electric Company | Techniques for neuromodulation |
-
2019
- 2019-04-30 US US16/399,692 patent/US11426610B2/en active Active
-
2020
- 2020-05-22 WO PCT/IB2020/054901 patent/WO2020222217A1/fr active Application Filing
- 2020-06-19 JP JP2021564086A patent/JP2022536025A/ja active Pending
- 2020-06-19 WO PCT/US2020/038665 patent/WO2020223741A2/fr unknown
- 2020-06-19 CN CN202080048471.3A patent/CN114080181A/zh active Pending
- 2020-06-19 EP EP20799050.8A patent/EP3962598A4/fr active Pending
-
2022
- 2022-07-13 US US17/864,212 patent/US20220362587A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
US20200346043A1 (en) | 2020-11-05 |
EP3962598A2 (fr) | 2022-03-09 |
WO2020222217A1 (fr) | 2020-11-05 |
EP3962598A4 (fr) | 2023-05-10 |
US20220362587A1 (en) | 2022-11-17 |
WO2020223741A2 (fr) | 2020-11-05 |
JP2022536025A (ja) | 2022-08-12 |
WO2020223741A3 (fr) | 2020-12-10 |
US11426610B2 (en) | 2022-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20220362587A1 (en) | Neuromodulation techniques for perturbation of physiological systems | |
US11911634B2 (en) | Neuromodulation energy application techniques | |
JP7404254B2 (ja) | 超音波ニューロモジュレーション技術 | |
JP2023058664A (ja) | ニューロモジュレーション技術 | |
US20230218276A1 (en) | Delivery of therapeutic neuromodulation | |
US11771368B2 (en) | Rapid assessment of microcirculation in patients to realize closed-loop systems | |
US20230226380A1 (en) | Noninvasive tissue displacement control and monitoring for neuromodulation | |
CN114786770A (zh) | 多束神经调节技术 | |
US20190261912A1 (en) | System and methods for identifying or assessing inflammatory bowel disease or gut inflammation | |
US12029577B2 (en) | Neuromodulation to target glucose transporter and/or incretin pathways | |
US20220175306A1 (en) | Neuromodulation to target glucose transporter and/or incretin pathways | |
US20240226609A1 (en) | Neuromodulation techniques |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |